08:00 , Feb 9, 2012 |  BC Innovations  |  Targets & Mechanisms

Going viral in Parkinson's disease

University of Cambridge researchers have fused a virus-derived peptide that crosses the blood brain barrier with a neuroprotective RNA to generate a conjugate that can be delivered noninvasively to the brain in Parkinson's disease models....